LAVSX
Price
$15.92
Change
+$0.11 (+0.70%)
Updated
Jul 3 closing price
Net Assets
2B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

LAVSX vs VVIAX

Header iconLAVSX vs VVIAX Comparison
Open Charts LAVSX vs VVIAXBanner chart's image
Lord Abbett Fundamental Equity R4
Price$15.92
Change+$0.11 (+0.70%)
VolumeN/A
Net Assets2B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
LAVSX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LAVSX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAVSX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. LAVSX (2B). VVIAX pays higher dividends than LAVSX: VVIAX (2.18) vs LAVSX (0.83). LAVSX was incepted earlier than VVIAX: LAVSX (10 years) vs VVIAX (25 years). LAVSX (0.95) is less costly to investors than VVIAX (0.05). LAVSX is a more actively managed with annual turnover of: 39.00 vs. VVIAX (9.00). LAVSX has a lower initial minimum investment than VVIAX: LAVSX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. LAVSX (9.13). VVIAX return over 5 years is better than : 80.13 vs. LAVSX (60.39).
LAVSXVVIAXLAVSX / VVIAX
Total Expense Ratio0.950.051,900%
Annual Report Gross Expense Ratio0.950.051,900%
Fund Existence10 years25 years-
Gain YTD6.4176.198104%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2B189B1%
Annual Yield % from dividends0.832.1838%
Returns for 1 year9.1312.0376%
Returns for 3 years38.5335.17110%
Returns for 5 years60.3980.1375%
Returns for 10 years26.64115.6723%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.